Literature DB >> 6779738

[Prognosis of primary non-obstructive cardiomyopathies].

G Convert, J Delaye, J Beaune, A Biron, A Gonin.   

Abstract

The prognosis of congestive cardiomyopathy was studied in 132 consecutive patients (110 male, 22 female, average age 45 +/- 11 years) in whom a thorough clinical evaluation had excluded a secondary cause. The patients presented with left ventricular failure, a history of systemic embolism, syncope or radiological cardiomegaly. Right (100 p. 100) and left (81 p. 100) heart catheterisation was performed and left ventricular endiastolic volumes (202 +/- 77 ml/m2) and ejection fractions (31 +/- 12 p. 100) calculated from angiography in the 30 degrees right anterior oblique projection. Regional abnormalities of contraction were observed in 32 patients. The average follow up period was 40,4 +/- 23,8 months. At the end of the study 48 patients (37 p. 100) had died and 2 had been lost to follow up. Survival rates were calculated by actuarial methods. Age, sex, the period they had been symptomatic, alcoholic intoxication and the degree of cardiac dilatation were not significant prognostic factors. Patients in Class IV NYHA had the worst prognosis: 63 p. 100 2 year mortality. Atrioventricular conduction defects were observed in 56 patients and were associated with a significantly increased mortality rate (43 p. 100 compared with 23 p. 100, p < 0.001). Atrial fibrillation (32 patients) was a better prognostic factor than the persistence of sinus rhythm; 2 year mortality 11,1 p. 100 compared to 37,6 p. 100 (p < 0.001). Increased left ventricular end diastolic pressures greater than 20 mmHg were related with a mortality of 51,5 p. 100. Also, the patients with a ejection fraction of 30 p. 100 and a 2 year mortality rate of 44 p. 100 compared to 17,5 p. 100 when the ejection fraction was greater than 30 p. 100 (p < 0,001). In conclusion : 1. Regional abnormalities of left ventricular contraction are not rare in primary cardiomyopathy. 2. The prognosis is directly related to the degree of cardiac failure and the extent of left ventricular dysfunction.

Entities:  

Mesh:

Year:  1980        PMID: 6779738

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  8 in total

1.  Mortality in heart failure: clinical variables of prognostic value.

Authors:  J G Cleland; H J Dargie; I Ford
Journal:  Br Heart J       Date:  1987-12

2.  Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste.

Authors:  Aneta Aleksova; Marco Merlo; Massimo Zecchin; Gastone Sabbadini; Giulia Barbati; Giancarlo Vitrella; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  Clin Med Res       Date:  2010-08-03

3.  Prediction of outcome in dilated cardiomyopathy.

Authors:  R A Diaz; A Obasohan; C M Oakley
Journal:  Br Heart J       Date:  1987-10

4.  Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy.

Authors:  Y Koga; T Wada; H Toshima; K Akazawa; Y Nose
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

5.  Prognosis and treatment of cardiomyopathy and myocarditis.

Authors:  J B O'Connell; M R Costanzo-Nordin; R S Engelmeier; D E Wallis; J A Robinson; P J Scanlon
Journal:  Heart Vessels Suppl       Date:  1985

6.  Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy.

Authors:  M Ciaccheri; G Castelli; F Cecchi; M Nannini; G Santoro; V Troiani; A Zuppiroli; A Dolara
Journal:  Br Heart J       Date:  1989-07

7.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

8.  National Trends in the Burden of Atrial Fibrillation During Hospital Admissions for Heart Failure.

Authors:  Samuel W Reinhardt; Fouad Chouairi; P Elliott Miller; Katherine A A Clark; Bradley Kay; Michael Fuery; Avirup Guha; James V Freeman; Tariq Ahmad; Nihar R Desai; Daniel J Friedman
Journal:  J Am Heart Assoc       Date:  2021-05-20       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.